Kymera Therapeutics, Inc.
2020 Q4 - 2025 Q4 (21 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 3,559 | 0.0% | 45,742 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 2,304 | 0.0% | 40,699 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 1,585 | 0.0% | 36,318 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 1,008 | 0.0% | 36,839 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 1,482 | 0.0% | 36,839 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 1,548 | 0.0% | 32,708 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 1,334 | 0.0% | 44,696 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 1,625 | 0.0% | 40,423 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 976 | 0.0% | 38,321 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 558 | 0.0% | 40,154 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 904 | 0.0% | 39,341 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 1,345 | 0.0% | 45,387 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 1,108 | 0.0% | 44,381 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 955 | 0.0% | 43,862 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 876 | 0.0% | 44,491 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 1,642 | 0.0% | 38,801 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 2,689 | 0.0% | 42,354 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 2,406 | 0.0% | 40,964 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 1,933 | 0.0% | 39,855 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 591 | 0.0% | 15,204 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 946 | 0.0% | 15,250 | 12/31/2020 |